NeuroAI NEUROAINEUROAI.SITE
China AI, reported clearly
1,300+ verified stories on models, robotics, BCI and the business of AI.
Browse stories
ESC

A Robot That Works Overnight in Pharmacies Just Raised ¥2.5 Billion

Galbot's funding shows how embodied intelligence is being sold into pharmacies and battery plants, where a robot must work unattended.

2026-11-22 · 906 words · NeuroAI
A Robot That Works Overnight in Pharmacies Just Raised ¥2.5 Billion

A pharmacy at midnight has no pharmacist behind the counter. A robot moves along the shelves, picks a package, and places it in a collection slot. The customer never sees a human being. This is not a demonstration staged for cameras; it is a business model that only works if the machine is reliable for hours without supervision.

Galbot (银河通用), a Beijing robotics company, has built its case on such unglamorous tasks. In March 2026 it announced a new financing round of ¥2.5 billion (≈ US$350M), according to People's Daily and other Chinese outlets. The company is led by Wang He (王鹤), a researcher at Peking University who founded an academic laboratory in embodied intelligence (具身智能) before turning to products.

Key takeaways

  • Galbot raised ¥2.5 billion (≈ US$350M) in a round announced in March 2026.
  • Its robots operate in smart pharmacies across 24 cities, managing more than 5,000 stock-keeping units per store.
  • An industrial model, Galbot S1, has a dual-arm maximum payload of 50 kg and is used in a CATL battery factory.
  • The company's G1 humanoid performed tasks autonomously on the 2026 CCTV Spring Festival Gala.
  • Investors include state-backed funds; reported valuations come from company and local-government sources, not a public filing.

The 10-things-well strategy

Wang He has described the strategy as aiming for ten things done to industrial standards rather than a hundred done superficially — a formulation the company uses in its own materials. That sentence explains the product line better than any specification sheet.

The retail product is a wheeled humanoid that works in what the company calls an instant-retail warehouse and smart pharmacy. According to People's Daily, this operation has run continuously around the clock for more than a year in 24 cities, with each site managing over 5,000 distinct products. A related format, the "Galaxy Capsule" convenience store, has been installed in more than 100 locations across over 20 cities.

These numbers matter because a robot in a public retail space cannot be remotely operated by a hidden technician at scale. It must recognise arbitrary products, handle unfamiliar packaging, and recover from errors. A pharmacy is also a demanding environment: small objects, similar-looking boxes, and real consequences for mistakes.

The industrial product is different. Galbot S1, which had launched in January 2026, is a heavy-duty humanoid with a reported dual-arm maximum load of 50 kilograms, designed to work in dust, vibration, and temperature variation. The company says it operates autonomously in a CATL battery factory and can swap its own batteries. Other named customers include Bosch, Toyota, BAIC, and SAIC, with cumulative orders described as being in the thousands of units.

Why the Spring Festival Gala mattered

In the 2026 CCTV Spring Festival Gala, a Galbot G1 appeared alongside comedians and performed tasks including cracking walnuts, picking up glass fragments, taking items from a shelf, folding clothes, and threading sausages. The company says the actions were decided in real time by its embodied model rather than executed as a fixed programme.

Television exposure is not technical evidence, but in the Chinese robotics market it has a practical function. It creates name recognition for industrial buyers and reassures local governments considering pilot projects. A robot that can handle a chaotic stage, with changing lights and unscripted interaction, is at least a credible starting point for a warehouse.

Reading the funding

The March round drew strategic and state-backed investors, including the National Artificial Intelligence Industry Investment Fund and Sinopec, according to local government reporting. Hangzhou authorities later described the company's valuation as exceeding ¥20 billion (≈ US$2.8B). Those figures come from company and government sources, not a listed-company disclosure, so they should be read as indicative.

In July 2026, Galbot signed a cooperation agreement with Qiantang district in Hangzhou to build demonstration scenarios and a training base. Such partnerships provide real sites for testing, which is often more valuable to a robotics company than cash.

The deeper question

Embodied intelligence (具身智能) has become the preferred term for systems that perceive, decide, and act in the physical world. The gap between a laboratory demonstration and a commercial robot is mostly a question of edge cases: the object nobody expected, the lighting that changed, the floor that is slightly slippery.

Galbot's bet is that a narrow task repeated thousands of times teaches more than a broad task performed once. Whether that approach generalises to new sites is the open question. A pharmacy in one city may not resemble a pharmacy in another, and each new customer adds integration work.

Honest limitations

  • The ¥2.5 billion round, the 24-city coverage, the 5,000-SKU figure, and the 50 kg payload are from Chinese media reporting company information. I found no independent audit.
  • "Continuous operation for more than a year" is a company claim without published uptime or error-rate data.
  • Customer relationships and order volumes are described in company releases; named manufacturers have not published confirmations in the sources reviewed.
  • The reported valuation comes from local-government and media accounts, not a regulatory filing.
  • Benchmark and capability claims about autonomous decision-making on stage were not accompanied by technical documentation.

What readers can do now

  • If you use an automated retail service, notice how it handles mistakes. Recovery behaviour tells you more about maturity than speed.
  • For business buyers, ask for error rates and human-intervention frequency, not maximum payload or degrees of freedom.
  • Treat funding announcements as a measure of investor confidence, not proof that the business model works at scale.

Related coverage

Cite this article

NeuroAI (脑机网), "A Robot That Works Overnight in Pharmacies Just Raised ¥2.5 Billion," 22 November 2026, https://neuroai.site/a/na-robot-galbot-pharmacy-funding

Machine-readable: BibTeX · RIS · JSON · Markdown

More in “Humanoids & Robotics” → · Back to home · Markdown version

China AI, reported clearly
1,300+ verified stories on models, robotics, BCI and the business of AI.
Browse stories